Evidence-Based Approach of Biologic Therapy in Bronchial Asthma

被引:1
|
作者
Liaqat, Adnan [1 ]
Mason, Mathew [2 ]
Foster, Brian [3 ]
Gregory, Grant [4 ]
Patel, Avani [5 ]
Barlas, Aisha [6 ]
Kulkarni, Sagar [7 ]
Basso, Rafaela [7 ]
Patak, Pooja [8 ]
Liaqat, Hamza [9 ]
Qureshi, Muhammad [7 ]
Shehata, Abdelrahman [7 ]
Awad, Yousef [7 ]
Ghaly, Mina [7 ]
Gulzar, Qamar [7 ]
Doty, Walter [7 ]
机构
[1] McLaren Hlth Michigan State Univ, Pulm & Crit Care Med, Flint, MI 48532 USA
[2] Baylor Coll Med, Internal Med, Houston, TX 77030 USA
[3] Cleveland Clin Florida, Pulm & Crit Care Med, Weston, FL 33321 USA
[4] Alabama Coll Osteopath Med, Internal Med, Dothan, AL 36303 USA
[5] Meharry Med Coll, Internal Med, Nashville, TN 37208 USA
[6] Mercy Hlth, Internal Med, Rockford, IL 61114 USA
[7] Southeast Hlth, Pulm & Crit Care Med, Dothan, AL 36301 USA
[8] Univ Missouri, Pulm & Crit Care Med, Kansas City, MO 64110 USA
[9] Wah Med Coll, Internal Med, Wah Cantt 47040, Pakistan
关键词
asthma; omalizumab; reslizumab; benralizumab; mepolizumab; dupilumab; tezepelumab; SEVERE EOSINOPHILIC ASTHMA; THYMIC STROMAL LYMPHOPOIETIN; DOUBLE-BLIND; INHALED CORTICOSTEROIDS; PERSISTENT ASTHMA; MEPOLIZUMAB; PLACEBO; TEZEPELUMAB; OMALIZUMAB; SAFETY;
D O I
10.3390/jcm12134321
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The emergence of biologic agents in the treatment of bronchial asthma has a wide impact on improving quality of life, reducing morbidity, and overall health care utilization. These therapies usually work by targeting specific inflammatory pathways involving type 2 inflammation and are particularly effective in severe eosinophilic asthma. Various randomized controlled trials have shown their effectiveness by reducing exacerbation rates and decreasing required glucocorticoid dosages. One of the relatively newer agents, tezepelumab, targets thymic stromal lymphoprotein and has proven its efficacy in patients independent of asthma phenotype and serum biomarker levels. This article reviews the pathophysiologic mechanism behind biologic therapy and offers an evidence-based discussion related to the indication, benefits, and adverse effects of such therapies.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] An update on biologic-based therapy in asthma
    Walsh, Garry M.
    [J]. IMMUNOTHERAPY, 2013, 5 (11) : 1255 - 1264
  • [22] The diagnosis of asthma in children: An evidence-based approach to a common clinical dilemma
    Masekela, R.
    Risenga, S. M.
    Kitchin, O. P.
    White, D. A.
    Davis, G.
    Goussard, P.
    Manjra, A. I.
    Kritzinger, F. E.
    Levin, M.
    Zar, H.
    Green, R. J.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2018, 108 (07): : 540 - 545
  • [23] Managing Asthma: An Evidence-Based Approach to Optimizing Inhaled Corticosteroid Treatment
    Fromer, Leonard
    [J]. SOUTHERN MEDICAL JOURNAL, 2010, 103 (10) : 1038 - 1044
  • [24] An evidence-based approach
    不详
    [J]. BRITISH DENTAL JOURNAL, 2016, 221 (03) : 100 - 100
  • [25] An evidence-based approach
    M A Torkington
    [J]. British Dental Journal, 1998, 184 : 423 - 423
  • [26] Biologic Therapy and Asthma
    Viswanathan, Ravi K.
    Busse, William W.
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 39 (01) : 100 - 114
  • [27] Evidence-Based Assessment Of The Anatomy Of The Bronchial Arteries
    Hsieh, W.
    Henry, B. M.
    Pekala, J.
    Graves, M.
    Pekala, P. A.
    Saganiak, K.
    Tomaszewski, K.
    Walocha, J. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [28] An evidence-based approach
    C Lister
    [J]. British Dental Journal, 1998, 184 (9) : 423 - 424
  • [29] Effectiveness of Evidence-Based Asthma Interventions
    Kennedy, Suzanne
    Bailey, Ryan
    Jaffee, Katy
    Markus, Anne
    Gerstein, Maya
    Stevens, M.
    Lesch, Julie Kennedy
    Malveaux, Floyd J.
    Mitchell, Herman
    [J]. PEDIATRICS, 2017, 139 (06)
  • [30] Evidence-based asthma education for parents
    Cleveland, Kelli K.
    [J]. JOURNAL FOR SPECIALISTS IN PEDIATRIC NURSING, 2013, 18 (01) : 25 - 32